Fight PAH in Systemic Sclerosis With Combination TherapyFight PAH in Systemic Sclerosis With Combination Therapy

Response is better when the initial treatment of pulmonary artery hypertension (PAH) in patients with systemic sclerosis is combination therapy, an analysis from the AMBITION trial has shown. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news